Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6765992 | 7061867 | F | 6765992-4 | 20100604 | 20100611 | EXP | A0787070A | GLAXOSMITHKLINE | 52 | YR | F | Y | 98.6 | KG | 20100611 | OT | UNITED STATES |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6765992 | 1013848767 | PS | AVANDIA | 1 | ORAL | 8MG PER DAY | 021071 | ||||
| 6765992 | 1013848768 | C | LISINOPRIL | 1 | |||||||
| 6765992 | 1013848769 | C | LASIX | 1 | |||||||
| 6765992 | 1013848770 | C | TRICOR | 1 | |||||||
| 6765992 | 1013848771 | C | AMARYL | 1 | |||||||
| 6765992 | 1013848772 | C | NEURONTIN | 1 | |||||||
| 6765992 | 1013848773 | C | LORCET-HD | 1 | |||||||
| 6765992 | 1013848774 | C | ZETIA | 1 | |||||||
| 6765992 | 1013848775 | C | CYMBALTA | 1 | |||||||
| 6765992 | 1013848776 | C | LOPRESSOR | 1 | |||||||
| 6765992 | 1013848777 | C | AMARYL | 1 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6765992 | 1013848767 | DIABETES MELLITUS |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6765992 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 6765992 | CARDIAC DISORDER |
| 6765992 | CORONARY ARTERY STENOSIS |
| 6765992 | MYOCARDIAL INFARCTION |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6765992 | 1013848767 | 20061005 | 20070719 | 288 | DAY |